HHS launches programs to speed clinical trials amid China competition
· Health · United States
The Department of Health and Human Services is offering funding to teams with innovative proposals and is considering ending the traditional phased clinical trial system. The move comes as Chinese competition in biopharma looms larger.
Why it matters：Reforming trial design could shorten drug development timelines industry-wide and shift how regulators and sponsors approach evidence generation.
Key points
- Funding is offered to teams with innovative proposals.
- HHS is considering ending the traditional phased trial system.
- The initiative is framed against looming Chinese competition.
Sources (original reporting)
More stories from this day
- Sanofi pays Regeneron $1B to expand antibody alliance
- Patient death clouds Bristol Myers fibrosis drug ahead of readout
- Devoted Health raises $1.2B as Medicare Advantage growth accelerates
- CMS finalizes GLOBE Medicare drug price demo with lower savings
- US and South Korea outline $120bn plan for eight nuclear units
- US, South Korea agree $120bn framework for eight nuclear reactors